High expression of preferentially expressed antigen of melanoma (PRAME) is necessary for TNF-related apoptosis-inducing ligand (TRAIL) resistance in human lymphoid leukemia cells [30]. The gene discussed is TNFSF10; the disease is lymphoid leukemia.